Pătru, R.-I.; Ghigeanu, M.; Barbu, M.-A.; Ionescu, A.I.; Ionuț-Lucian, A.-I.
Type I Diabetes—A Rare Adverse Event Described in Patients Receiving Immunotherapy Versus a Side Effect from SARS-CoV-2 Infection. Reports 2025, 8, 31.
https://doi.org/10.3390/reports8010031
AMA Style
Pătru R-I, Ghigeanu M, Barbu M-A, Ionescu AI, Ionuț-Lucian A-I.
Type I Diabetes—A Rare Adverse Event Described in Patients Receiving Immunotherapy Versus a Side Effect from SARS-CoV-2 Infection. Reports. 2025; 8(1):31.
https://doi.org/10.3390/reports8010031
Chicago/Turabian Style
Pătru, Raluca-Ileana, Miruna Ghigeanu, Maria-Alexandra Barbu, Andreea Iuliana Ionescu, and Antone-Iordache Ionuț-Lucian.
2025. "Type I Diabetes—A Rare Adverse Event Described in Patients Receiving Immunotherapy Versus a Side Effect from SARS-CoV-2 Infection" Reports 8, no. 1: 31.
https://doi.org/10.3390/reports8010031
APA Style
Pătru, R.-I., Ghigeanu, M., Barbu, M.-A., Ionescu, A. I., & Ionuț-Lucian, A.-I.
(2025). Type I Diabetes—A Rare Adverse Event Described in Patients Receiving Immunotherapy Versus a Side Effect from SARS-CoV-2 Infection. Reports, 8(1), 31.
https://doi.org/10.3390/reports8010031